Synthetic biology produces novel antibiotic

Researchers at the University of California, San Diego say they have developed a new genetic platform that allows efficient production of naturally occurring molecules. They then used it to produce a novel antibiotic compound, they add.

The UC-San Diego team believes their study (“Direct cloning and refactoring of a silent lipopeptide biosynthetic gene cluster yields the antibiotic taromycin A”), which is published in the Proceedings of the National Academy of Sciences, may open new avenues for natural product discoveries and drug development.

According to lead investigator Bradley S. Moore, Ph.D., of the Scripps Institution of Oceanography and Skaggs School of Pharmacy and Pharmaceutical Sciences at UC-San Diego, the findings demonstrate a “plug-and-play” technique to trigger previously unknown biosynthetic pathways and identify natural product drug candidates.

Read the full, original story: Synthetic Biology Technique Used to Produce Novel Antibiotic

Outbreak
Outbreak Daily Digest
Biotech Facts & Fallacies
Genetics Unzipped
Infographic: How dangerous COVID mutant strains develop

Infographic: How dangerous COVID mutant strains develop

Sometime in 2019, probably in China, SARS CoV-2 figured out a way to interact with a specific "spike" on the ...
Untitled

Philip Njemanze: Leading African anti-GMO activist claims Gates Foundation destroying Nigeria

Nigerian anti-GMO activist, physician, and inventor pushes anti-gay and anti-GMO ...
News on human & agricultural genetics and biotechnology delivered to your inbox.
glp menu logo outlined

Newsletter Subscription

Optional. Mail on special occasions.
Send this to a friend